Abbott India Limited Abbott India Limited

Abbott India Limited

ABBOTINDIA

Rankning i aktier #3023
Abbott India Limited is a pharmaceutical enterprise that conducts its... Abbott India Limited is a pharmaceutical enterprise that conducts its operations across India. The company provides an extensive portfolio of medicinal products designed for a broad spectrum of therapeutic areas, including women's health, digestive conditions, metabolic disorders, central nervous system ailments, pain management, premature labor concerns, vitamin supplementation, sleep aids, immunizations, and general consumer health items. Established in 1944, the firm was formerly known as Knoll Pharmaceuticals Limited until it officially adopted the name Abbott India Limited in July 2002. Headquartered in Mumbai, India, it operates as a subsidiary of Abbott Capital India Limited.
Aktiekurs
$284.73
Marknadsvärde
$6.05B
Förändring (1 dag)
-0.41%
Förändring (1 år)
-17.16%
Land
IN
Handel Abbott India Limited (ABBOTINDIA)

Kategori

Healthcare
Vinst för Abbott India Limited (ABBOTINDIA)
Vinst i Jun 2026 TTM: $238.19M
Enligt de senaste finansiella rapporterna från Abbott India Limited är företagets nuvarande vinst $238.19M. År 2024 hade företaget en vinst på $194.01M, en ökning jämfört med vinsten år 2023 som var $155.00M. Vinsten som visas på denna sida är vinsten före räntor och skatt, även kallad EBIT.
Vinshistorik för Abbott India Limited från 2004 till 2026
Vinst vid slutet av varje år
År Vinst Ändra
2026 (TTM) $238.19M 7.96%
2025 $220.63M 13.72%
2024 $194.01M 25.17%
2023 $155.00M 8.97%
2022 $142.24M 12.45%
2021 $126.49M 18.71%
2020 $106.55M 5.87%
2019 $100.64M 5.44%
2018 $95.45M 41.81%
2017 $67.31M 12.04%
2016 $60.08M 8.86%
2015 $55.19M 39.00%
2014 $39.70M 1.44%
2012 $39.14M 15.33%
2011 $33.94M 61.11%
2010 $21.06M -16.67%
2009 $25.28M 33.27%
2008 $18.97M -26.36%
2007 $25.76M 31.50%
2006 $19.59M 3.19%
2005 $18.98M -38.51%
2004 $30.87M 0.00%
Vinst för liknande företag eller konkurrenter
Företag Vinst Skillnad i vinst Land
$33.60B 14,004.37%
US
$17.74B 7,346.49%
US
$8.70B 3,552.08%
US
$5.95B 2,397.14%
US
$21.39B 8,879.40%
CH